Anterogen Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
916
1,834
3,532
4,896
5,357
Cost of Goods Sold (COGS) incl. D&A
785
1,013
1,413
1,606
2,342
Gross Income
131
821
2,119
3,290
3,015
SG&A Expense
2,034
2,401
2,212
3,158
2,788
EBIT
1,906
1,586
121
121
149
Unusual Expense
55
-
-
-
395
Non Operating Income/Expense
63
64
67
40
75
Interest Expense
-
-
-
-
61
Pretax Income
1,810
1,416
58
372
739
Consolidated Net Income
1,810
1,416
58
372
739
Net Income
1,810
1,416
58
372
739
Net Income After Extraordinaries
1,810
1,416
58
372
739
Net Income Available to Common
1,810
1,416
58
372
739
EPS (Basic)
226.84
177.43
7.31
50.00
95.00
Basic Shares Outstanding
8
8
8
7
8
EPS (Diluted)
226.84
177.43
7.31
50.24
60.39
Diluted Shares Outstanding
8
8
8
7
8
EBITDA
1,653
1,322
171
432
540
Other Operating Expense
4
6
28
12
78
Non-Operating Interest Income
215
234
130
291
331
About Anterogen Co.
View Profile
